Graft-versus-host disease and immunosuppression

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Immunologic research

• Publication date

  2008-03-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12026-007-0026-yPMID 18317708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

  2006cited by this paper
• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

  2005cited by this paper
• Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

  2005cited by this paper
• Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.

  2005cited by this paper
• Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

  2005cited by this paper
• Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

  2005cited by this paper
• A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.

  2005cited by this paper
• Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

  2004cited by this paper
• Graft-versus-host disease: how to translate new insights into new therapeutic strategies.

  2004cited by this paper
• Graft-versus-host disease of the skin: life and death on the epidermal edge.

  2004cited by this paper
• Chronic graft versus host disease

  2004cited by this paper
• Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

  2004cited by this paper
• Duration of immunosuppressive treatment for chronic graft-versus-host disease.

  2004cited by this paper
• Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

  2004cited by this paper
• Chronic graft-versus-host disease.

  2003cited by this paper
• Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

  2001cited by this paper
• Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.

  2001cited by this paper
• Hydroxychloroquine for the treatment of chronic graft-versus-host disease.

  2000cited by this paper
• Pathogenesis of Acute Graft-Versus-Host Disease: Cytokines and Cellular Effectors

  2000cited by this paper
• Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.

  1999cited by this paper
• Bone marrow transplantation for sickle cell disease.

  1996cited by this paper
• Marrow transplantation in patients with thalassemia responsive to iron chelation therapy.

  1993cited by this paper
• Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.

  1988cited by this paper
• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper
• Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

  1983cited by this paper
• Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

  1981cited by this paper
• Immunological reconstitution of sex-linked lymphopenic immunological deficiency.

  1968cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper
• Quantitative studies on tissue transplantation immunity IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease

  1959cited by this paper

• Severe Sepsis-Associated Morbidity and Mortality among Critically Ill Children with Cancer

  2018cites this paper
• Immunorégulation de la réaction du greffon contre l'hôte (GvHD) dans un modèle murin xénogénique : le rôle des immunoglobulines intraveineuses (IVIG)

  2015cites this paper